SecurityCBS.A / CBS Corp. (124857103)
Chairman, President & CEOMOONVES LESLIE
IndustryTelevision Broadcasting Stations
Institutional Owners58
Institutional Shares36,476,426 - 10.78%
Common Shares Outstanding2338,524,891 shares (as of 2018-06-30)
Institutional Value$ 370,975,000 USD
Related CBS / CBS Corp.
124857AH6 / Cbs Corp 1.95% 07/01/17
124857AG8 / Cbs Corp 3.375% 03/01/22
124857AE3 / Cbs Corp 4.3% 02/15/21
124857AJ2 / Cbs Corp 4.85% 07/01/42
124857AF0 / Cbs Corp 5.9% 10/15/40
CPV / CBS Corp. 6.75% Senior Bond Due 3/27/2056
124857AA1 / Cbs Corp. 7.625% Sr. Debentures 1/15/16
124857AC7 / Cbs Corp 8.875% 05/15/19
CBS.WD / CBS Corporation
925524AU4 / Viacom Corp 4.625% Senior Notes 05/15/18
925524AV2 / Viacom Corp 5.500% Senior Debentures 05/15/33
925524AH3 / Viacom Corp 7.875% Senior Debentures 07/30/30
960394AP9 / Westinghouse Cr Corp Notes 8.875% 06/14/14

Institutional Stock Ownership and Shareholders

CBS.A / CBS Corp. Institutional Ownership

CBS Corp. (NYSE:CBS.A) has 58 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,476,426 shares. Largest shareholders include National Amusements Inc /md/, Gruss Capital Management LP, Gamco Investors, Inc. Et Al, Gabelli Funds Llc, Renaissance Technologies LLC, RMB Capital Management, LLC, Millennium Management Llc, Pacific Heights Asset Management Llc, Dimensional Fund Advisors Lp, and Vanguard Group Inc.
CBS Corp. (NYSE:CBS.A) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 0 11,833 0 670
2018-08-15 13F-HR TANAKA CAPITAL MANAGEMENT INC 20,968 35,518 69.39 1,078 1,997 85.25
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 29 29 0.00 1 2 100.00
2018-08-13 13F-HR Renaissance Technologies LLC 315,600 16,234
2018-08-03 13F-HR/A WESPAC Advisors SoCal, LLC 122 0 -100.00 6 0 -100.00
2018-08-03 13F-HR Sandy Spring Bank 160 160 0.00 8 9 12.50
2018-08-14 13F-HR CSS LLC/IL 296 859 190.20 15 49 226.67
2018-08-09 13F-HR BlackRock Inc. 6,652 8,849 33.03 342 500 46.20
2018-08-14 13F-HR MORGAN STANLEY 4,721 2,938 -37.77 243 165 -32.10
2018-08-01 13F-HR FIRST MANHATTAN CO 20,000 20,000 0.00 1,028 1,129 9.82
2018-08-14 13F-HR DEUTSCHE BANK AG\ 11,534 6,365 -44.82 593 359 -39.46
2018-08-08 13F-HR US BANCORP \DE\ 30 30 0.00 2 2 0.00
2018-08-14 13F-HR Pacific Global Investment Management CO 5,328 5,332 0.08 274 302 10.22
2018-08-13 13F-HR CAPTRUST FINANCIAL ADVISORS 34 34 0.00 2 2 0.00
2018-08-13 13F-HR Gruss Capital Management LP 2,479,900 2,479,900 0.00 127,566 140,090 9.82
2018-08-14 13F-HR ROYAL BANK OF CANADA 153 178 16.34 8 10 25.00
2018-07-26 13F-HR Sterling Investment Advisors, Ltd. 80 80 0.00 4 4 0.00
2018-08-10 13F-HR GABELLI FUNDS LLC 1,507,300 1,499,800 -0.50 77,536 84,724 9.27
2017-02-10 13F-HR BlackRock Advisors LLC 350 350 0.00 19 23 21.05
2018-08-07 13F-HR Harbor Advisors LLC 5,000 5,000 0.00 257 282 9.73
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 1,251 1,221 -2.40 65 68 4.62
2018-07-17 13F-HR MEAG MUNICH ERGO KAPITALANLAGEGESELLSCHAFT MBH 108,932 32,345 -70.31 5,627 1,831 -67.46
2018-09-18 13F-HR/A NORTHERN TRUST CORP 4,638 5,420 16.86 238 306 28.57
2018-08-14 13F-HR BARCLAYS PLC 8 0 -100.00 0 0
2018-08-13 13F-HR WAYNE HUMMER INVESTMENTS L.L.C. 14,650 828
2018-08-14 13F-HR UBS Group AG 2,313 618 -73.28 119 35 -70.59
2018-08-14 13F-HR Resources Investment Advisors, Inc. 500 500 0.00 26 28 7.69
2018-08-07 13F-HR LEVIN CAPITAL STRATEGIES, L.P. 0 8,600 0 486
2018-07-17 13F-HR Baystate Wealth Management LLC 20 44 120.00 1 3 200.00
2018-08-10 13F-HR CITIGROUP INC 5 11 120.00 0 1
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 30,811 0 -100.00 1,592 0 -100.00
2018-08-03 13F-HR Seacrest Wealth Management, Llc 306 306 0.00 16 17 6.25
2018-08-14 13F-HR GRUSS & CO INC 40,000 0 -100.00 2,056 0 -100.00
2018-07-25 13F-HR/A NWAM LLC 4,840 0 -100.00 249 0 -100.00
2018-08-02 13F-HR PARK CIRCLE Co 500 500 0.00 26 28 7.69
2018-08-14 13F-HR Walleye Trading LLC 5,982 5,982 0.00 308 338 9.74
2018-08-14 13F-HR VANGUARD GROUP INC 37,417 42,374 13.25 1,934 2,400 24.10
2018-08-08 13F-HR Glassman Wealth Services 255 256 0.39 13 14 7.69
2018-08-14 13F-HR Jacobi Capital Management LLC 1,050 0 -100.00 53 0 -100.00
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 63,930 58,531 -8.45 3,304 3,315 0.33
2018-07-27 13F-HR Advisory Services Network, LLC 8 8 0.00 0 0
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 40 0 -100.00 2 0 -100.00
2018-07-20 13F-HR North Star Investment Management Corp. 270 270 0.00 14 15 7.14
2017-10-26 13F-HR Acrospire Investment Management LLC 29 0 -100.00 2 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 745 730 -2.01 41 47 14.63
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 94 94 0.00 6 6 0.00
2018-08-02 13F-HR Pineno Levin & Ford Asset Management, Inc. 7,140 7,040 -1.40 367 396 7.90
2018-08-10 13F-HR GABELLI SECURITIES, INC. 9,242 10,450 13.07 475 590 24.21
2018-05-11 13F-HR CITIGROUP INC 305 5 -98.36 18 0 -100.00
2018-07-18 13F-HR Fny Investment Advisers, Llc 254 14
2018-07-05 13F-HR Clarus Wealth Advisors 26 1
2018-08-10 13F-HR BROWN ADVISORY INC 12,249 11,749 -4.08 630 664 5.40
2018-07-26 13F-HR REGIONS FINANCIAL CORP 157 157 0.00 8 9 12.50
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 10,293 12,279 19.29 530 694 30.94
2018-07-27 13F-HR PACIFIC HEIGHTS ASSET MANAGEMENT LLC 100,000 100,000 0.00 5,168 5,664 9.60
2017-02-13 SC 13G/A NATIONAL AMUSEMENTS INC /MD/ 29,882,639
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 3,366 0 190
2017-02-10 13F-HR BlackRock Fund Advisors 4,548 4,955 8.95 252 321 27.38
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 101,510 100,044 -1.44 5,246 5,666 8.01
2018-08-13 13F-HR RMB Capital Management, LLC 100,187 5,660
2018-08-10 13F-HR WASHINGTON TRUST Co 50 3
2018-07-24 13F-HR BALDWIN BROTHERS INC/MA 3 3 0.00 0 0
2018-07-25 13F-HR BECK MACK & OLIVER LLC 4,200 4,200 0.00 216 237 9.72
2018-04-18 13F-HR/A FNY Partners Fund LP 54 254 370.37 3 13 333.33
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 1,766 1,751 -0.85 91 99 8.79
2018-08-10 13F-HR GAMCO INVESTORS, INC. ET AL 1,702,797 1,671,652 -1.83 87,592 94,432 7.81
2018-08-07 13F-HR IFP Advisors, Inc 50 3

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

ESPN streaming service surpasses one million subscribers

2018-09-21 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (29-0)

Canada’s Tilray most valuable cannabis company after stock soars

2018-09-19 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (18-2)

Julie Chen bids farewell to 'The Talk' after Moonves allegations

2018-09-18 reuters
NEW YORK (Reuters) - Julie Chen, the wife of former CBS Corp 1-0)

CBS: A Lot Has Changed For Investors

2018-09-16 seekingalpha
CBS's stock has been stagnant/declining recently due to the bitter dispute over whether to merge with Viacom or not. (1-0)

PRESS DIGEST-New York Times business news - Sept 13

2018-09-13 reuters
Sept 13 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. (2-0)

Coverup was last straw in Moonves' ouster from CBS: report

2018-09-13 marketwatch
The last straw that led to the ouster of CBS Corp. CBS, -0.47% Chief Executive Les Moonves was not the new claims of sexual assault and harassment in a New Yorker article Sunday, but revelations in August that he was being blackmailed by one of his alleged victims and was trying to get her a job to secure her silence, the New York Times reported late Wednesday. Moonves still had strong support from some CBS board members after the first allegations against him were published by the New Yorker in July, the Times said. (1-0)

10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends

2018-09-12 investorplace
Whenever the stock market marches higher, it pushes the prices of many companies higher along with it. But as investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend stocks for long-term investors. (89-0)

Viacom Stock Isn’t Cheap Enough on Its Own

2018-09-12 investorplace
Viacom (NASDAQ:VIA,VIAB) unquestionably is cheap. The B shares of Viacom stock trade at barely seven times 2018 consensus EPS estimates. VIAB stock also has an attractive 2.76% dividend yield. (37-0)

60 Minutes Jeff Fager leaving CBS after reports of inappropriate behavior

2018-09-12 reuters
(Reuters) - The executive producer of the CBS television program “60 Minutes,” Jeff Fager, is leaving CBS News, according to a company memo on Wednesday, amid reports of inappropriate behavior. (1-0)

CBS downgraded to neutral from buy at UBS

2018-09-11 marketwatch
CBS Corp. was downgraded to neutral from buy on Monday by analysts at UBS, who cited uncertainty around the exit of Les Moonves, the company's longtime chair and chief executive. UBS also decreased the company's CBS, -0.54% price target to $60 from $72. Moonves resigned Sunday following new sexual misconduct allegations against him from six additional women. Joseph Ianniello, the company's chief operating officer, now takes the helm as interim CEO while the board searches for a permanent successor. (1-0)

CUSIP: 124857103